Shenzhen Ruisheng Equity Investment Fund Partnership (Limited Partnership)
Relying on advantage of the platform resource and industrial agglomeration of dongsheng science and technology park in zhongguancun, ruisheng investment buite the whole chain investment system. Fund manager: shenzhen ruisheng equity investment fund partnership (limited partnership) (registration code: P1034628). To early stage venture fund, incubation fund, late for partial equity investment for the project has a mezzanine fund, stock bonds combined investment, m&a, etc., at the same time, in which foreign involved as an LP covers health, artificial intelligence, new materials, consumption and new energy fields of four professional fund, key node layout industrial chain.
明明 杜
投资总监Shenzhen Wanhe Pharma
Established in Shenzhen Special Economic Zone in 1992;
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Monica Zhou
BDShijiazhuang yuanjia biotechnology co.,ltd
Focus on new drug license in china and license out of china,based in Shijiazhuang and Beijing.
从海 黄
创始人兼CEOSichuan Kelun-Biotech Biopharmaceutical Co., Ltd
Kelun-Biotech Biopharmaceutical is a subsidiary of Kelun Pharmaceutical Group established in 2016, focusing on innovative small molecules, biologucs, generics, and new drug delivery system(NDDS).